Weight Management Drugs

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Alternate detailed view >

Generic Name Brand Name Form PDL
Status
Current Drug Use Criteria Carveout
‐ Bill FFS
New Drug Evaluation & Updates
tirzepatide ZEPBOUND PEN INJCTR Y Pharmacy PA N Apr 03, 2025
liraglutide SAXENDA PEN INJCTR N Pharmacy PA N Mar 31, 2016
liraglutide LIRAGLUTIDE PEN INJCTR N Pharmacy PA N  
benzphetamine HCl BENZPHETAMINE HCL TABLET Pharmacy PA N  
diethylpropion HCl DIETHYLPROPION HCL TABLET Pharmacy PA N  
diethylpropion HCl DIETHYLPROPION HCL ER TABLET ER Pharmacy PA N  
orlistat XENICAL CAPSULE Pharmacy PA N  
orlistat ORLISTAT CAPSULE Pharmacy PA N  
phendimetrazine tartrate PHENDIMETRAZINE TARTRATE ER CAPSULE ER Pharmacy PA N  
phendimetrazine tartrate PHENDIMETRAZINE TARTRATE TABLET Pharmacy PA N  
phentermine HCl PHENTERMINE HCL CAPSULE Pharmacy PA N  
phentermine HCl LOMAIRA TABLET Pharmacy PA N  
phentermine HCl ADIPEX-P TABLET Pharmacy PA N  
phentermine HCl PHENTERMINE HCL TABLET Pharmacy PA N  
phentermine/topiramate PHENTERMINE-TOPIRAMATE ER CPMP 24HR Pharmacy PA N  
semaglutide WEGOVY PEN INJCTR Pharmacy PA N  
setmelanotide acetate IMCIVREE VIAL Pharmacy PA N Apr 01, 2021
tirzepatide ZEPBOUND VIAL Pharmacy PA N Apr 03, 2025